Global Phage Therapy Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Phage Therapy Kits market size was valued at US$ 43.1 million in 2024 and is forecast to a readjusted size of USD 115 million by 2031 with a CAGR of 15.2% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
Phage therapy, the therapeutic use of bacteriophages (viruses that infect bacteria), is a promising field with significant potential to address the growing challenge of antibiotic resistance. As such, the market for phage therapy kits is expected to experience substantial growth in the coming years.
Here are some key trends that are likely to shape the future market for phage therapy kits:
1. Increasing Prevalence of Antibiotic Resistance:
Rising antibiotic resistance: The overuse and misuse of antibiotics have led to a global increase in antibiotic-resistant bacteria, making traditional treatments less effective. This will drive demand for alternative solutions like phage therapy.
Expanded applications: Phage therapy is being explored for a wide range of infections, including skin infections, urinary tract infections, and respiratory infections. As research progresses and clinical trials demonstrate efficacy, the market for phage therapy kits will expand.
2. Advancements in Phage Research and Development:
Improved phage identification and characterization: Technological advancements will enable faster and more accurate identification and characterization of phages, leading to the development of more targeted and effective phage therapy kits.
Enhanced phage engineering: Researchers are exploring ways to engineer phages to improve their therapeutic properties, such as increasing their stability, broadening their host range, and enhancing their ability to overcome bacterial defenses.
3. Growing Regulatory Acceptance:
Regulatory approvals: As regulatory bodies gain more experience with phage therapy, we can expect to see an increase in approvals for phage therapy products. This will provide greater market access and boost investor confidence.
International collaboration: Global cooperation and harmonization of regulatory frameworks will facilitate the development and commercialization of phage therapy kits across different regions.
4. Increased Investment and Industry Interest:
Venture capital and pharmaceutical investments: The potential of phage therapy to address the antibiotic resistance crisis has attracted significant investment from venture capital firms and pharmaceutical companies. This increased interest will drive innovation and accelerate the development of phage therapy kits.
Partnerships and collaborations: Strategic partnerships between academic institutions, research organizations, and biotechnology companies will foster collaboration and accelerate the translation of phage therapy research into commercial products.
5. Personalized Phage Therapy:
Tailored phage cocktails: Advancements in genomics and personalized medicine will enable the development of customized phage cocktails that are specifically tailored to individual patients and their unique infections.
Precision phage therapy: This approach will improve treatment outcomes and reduce the risk of adverse effects.
Overall, the future market for phage therapy kits is poised for significant growth driven by the increasing prevalence of antibiotic resistance, advancements in phage research, regulatory acceptance, increased investment, and the potential for personalized phage therapy. As the field continues to evolve, we can expect to see a wider range of phage therapy products becoming available to patients, offering new hope for the treatment of antibiotic-resistant infections.
This report is a detailed and comprehensive analysis for global Phage Therapy Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Phage Therapy Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phage Therapy Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phage Therapy Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BiomX, PhagePro, PhagoMed Biopharma, MYRIADE, DotBio, Wuhan Greinon Biotechnology, PhagePharm, iNtRON Biotechnology, Snipr Technologies, CJ, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Phage Therapy Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medical Grade
Laboratory Grade
Market segment by Application
Medical
Food Industry
Agriculture
Others
Major players covered
BiomX
PhagePro
PhagoMed Biopharma
MYRIADE
DotBio
Wuhan Greinon Biotechnology
PhagePharm
iNtRON Biotechnology
Snipr Technologies
CJ
Phico Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Phage Therapy Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Phage Therapy Kits, with price, sales quantity, revenue, and global market share of Phage Therapy Kits from 2020 to 2025.
Chapter 3, the Phage Therapy Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Phage Therapy Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phage Therapy Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Phage Therapy Kits.
Chapter 14 and 15, to describe Phage Therapy Kits sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
Phage therapy, the therapeutic use of bacteriophages (viruses that infect bacteria), is a promising field with significant potential to address the growing challenge of antibiotic resistance. As such, the market for phage therapy kits is expected to experience substantial growth in the coming years.
Here are some key trends that are likely to shape the future market for phage therapy kits:
1. Increasing Prevalence of Antibiotic Resistance:
Rising antibiotic resistance: The overuse and misuse of antibiotics have led to a global increase in antibiotic-resistant bacteria, making traditional treatments less effective. This will drive demand for alternative solutions like phage therapy.
Expanded applications: Phage therapy is being explored for a wide range of infections, including skin infections, urinary tract infections, and respiratory infections. As research progresses and clinical trials demonstrate efficacy, the market for phage therapy kits will expand.
2. Advancements in Phage Research and Development:
Improved phage identification and characterization: Technological advancements will enable faster and more accurate identification and characterization of phages, leading to the development of more targeted and effective phage therapy kits.
Enhanced phage engineering: Researchers are exploring ways to engineer phages to improve their therapeutic properties, such as increasing their stability, broadening their host range, and enhancing their ability to overcome bacterial defenses.
3. Growing Regulatory Acceptance:
Regulatory approvals: As regulatory bodies gain more experience with phage therapy, we can expect to see an increase in approvals for phage therapy products. This will provide greater market access and boost investor confidence.
International collaboration: Global cooperation and harmonization of regulatory frameworks will facilitate the development and commercialization of phage therapy kits across different regions.
4. Increased Investment and Industry Interest:
Venture capital and pharmaceutical investments: The potential of phage therapy to address the antibiotic resistance crisis has attracted significant investment from venture capital firms and pharmaceutical companies. This increased interest will drive innovation and accelerate the development of phage therapy kits.
Partnerships and collaborations: Strategic partnerships between academic institutions, research organizations, and biotechnology companies will foster collaboration and accelerate the translation of phage therapy research into commercial products.
5. Personalized Phage Therapy:
Tailored phage cocktails: Advancements in genomics and personalized medicine will enable the development of customized phage cocktails that are specifically tailored to individual patients and their unique infections.
Precision phage therapy: This approach will improve treatment outcomes and reduce the risk of adverse effects.
Overall, the future market for phage therapy kits is poised for significant growth driven by the increasing prevalence of antibiotic resistance, advancements in phage research, regulatory acceptance, increased investment, and the potential for personalized phage therapy. As the field continues to evolve, we can expect to see a wider range of phage therapy products becoming available to patients, offering new hope for the treatment of antibiotic-resistant infections.
This report is a detailed and comprehensive analysis for global Phage Therapy Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Phage Therapy Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Phage Therapy Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phage Therapy Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phage Therapy Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BiomX, PhagePro, PhagoMed Biopharma, MYRIADE, DotBio, Wuhan Greinon Biotechnology, PhagePharm, iNtRON Biotechnology, Snipr Technologies, CJ, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Phage Therapy Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medical Grade
Laboratory Grade
Market segment by Application
Medical
Food Industry
Agriculture
Others
Major players covered
BiomX
PhagePro
PhagoMed Biopharma
MYRIADE
DotBio
Wuhan Greinon Biotechnology
PhagePharm
iNtRON Biotechnology
Snipr Technologies
CJ
Phico Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Phage Therapy Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Phage Therapy Kits, with price, sales quantity, revenue, and global market share of Phage Therapy Kits from 2020 to 2025.
Chapter 3, the Phage Therapy Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Phage Therapy Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phage Therapy Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Phage Therapy Kits.
Chapter 14 and 15, to describe Phage Therapy Kits sales channel, distributors, customers, research findings and conclusion.
Table of Contents
109 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Phage Therapy Kits by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
